What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol

BACKGROUND: Advanced cancer patients often experience multiple symptoms at a same time. This might lead to polypharmacy and increase adverse events representing major threats to the quality of health care, especially in palliative care situations. Mirtazapine, an antidepressant agent, has been sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Economos, Guillaume, Alexandre, Marine, Perceau-Chambard, Elise, Villeneuve, Laurent, Subtil, Fabien, Haesebaert, Julie, Glehen, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125889/
https://www.ncbi.nlm.nih.gov/pubmed/35599320
http://dx.doi.org/10.1186/s12904-022-00976-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125889/
https://www.ncbi.nlm.nih.gov/pubmed/35599320
http://dx.doi.org/10.1186/s12904-022-00976-7

Ejemplares similares